Glaxosmithkline | 판매 및 관리 비용



Selling And Administration Expenses 변화 날짜
AbbVie USD 3.29B 562M 2025-03
Amgen USD 1.88B 253M 2024-12
AstraZeneca USD 3.59B 1.96B 2025-03
Aurora Cannabis CAD 38.18M 2.05M 2024-12
Bausch Health Companies USD 867M 47M 2025-03
Bristol-Myers Squibb USD 1.58B 521M 2025-03
Canopy Growth CAD 40.62M 308K 2024-12
Corcept Therapeutics USD 83.37M 9.63M 2024-12
Drreddys Laboratories INR 21.59B 436M 2024-12
Eli Lilly USD 2.42B 324.7M 2024-12
GlaxoSmithKline GBP 2.06B 603M 2025-03
Glaxosmithkline GBP 2.7B 632M 2024-12
Indivior 132M 179M 2025-03
J&J USD 5.11B 1.34B 2025-03
Merck USD 2.53B 319M 2025-03
Novartis USD 3.5B 368M 2024-12
Pacira USD 79.61M 5.28M 2024-12
Perrigo USD 234.8M 36.7M 2024-12
Pfizer USD 3.01B 1.27B 2025-03
Prestige Brands USD 64.13M 3.35M 2024-12
Roche Holding CHF 3.61B 381M 2024-12
Sanofi EUR 2.22B 980M 2025-03
Supernus Pharmaceuticals USD 79.41M 9.66M 2024-12
Takeda JPY 270.59B 2.31B 2024-12
Teva Pharmaceutical Industries USD 952M 28M 2024-12
Zoetis USD 625M 60M 2024-12



Glaxosmithkline 판매 및 관리 비용 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - May 2025.